As of Feb 05
| -0.12 / -2.08%|
The 6 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 12.75, with a high estimate of 16.00 and a low estimate of 9.00. The median estimate represents a +126.06% increase from the last price of 5.64.
The current consensus among 6 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.